ArticleAlzheimer's research & therapy2021

In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer's disease phases.

Arianna Sala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.